Investing

Investing Cash Flow

Year-over-year, this metric declined by 110.4%, from $730.00M to -$76.00M.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026

How to read this metric

A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.

Detailed definition

This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...

Peer comparison

Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.

Metric ID: net_cash_from_investing

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q4 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$3.88B-$3.33B-$1.14B-$3.92B-$1.15B-$1.05B$2.01B$1.94B$789.00M$118.00M$1.65B$721.00M$730.00M$564.00M$700.00M$0.00-$76.00M
QoQ Change+14.2%+65.8%-244.6%+70.6%+9.0%+291.9%-3.3%-59.4%-85.0%>999%-56.3%+1.2%-22.7%+24.1%-100.0%
YoY Change+70.3%+7.9%+151.3%+268.8%-94.1%-15.2%-8.6%+518.6%-65.8%-2.9%-110.4%
Range-$3.92B$2.01B
CAGR-62.6%
Avg YoY Growth+65.4%
Median YoY Growth-2.9%
Current Streak2 quarters decline

Frequently Asked Questions

What is Moderna's investing cash flow?
Moderna (MRNA) reported investing cash flow of -$76.00M in Q1 2026.
How has Moderna's investing cash flow changed year-over-year?
Moderna's investing cash flow decreased by 110.4% year-over-year, from $730.00M to -$76.00M.
What does investing cash flow mean?
The net amount of cash spent on or received from investing activities.